Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Correction

Correction: A Hypoxia-Inducible HIF1–GAL3ST1–Sulfatide Axis Enhances ccRCC Immune Evasion via Increased Tumor Cell–Platelet Binding

DOI: 10.1158/1541-7786.MCR-20-0986 Published April 2021
  • Article
  • Info & Metrics
  • PDF
Loading

In the original version of this article (1), the authors reproduced, without permission, material that was published in a thesis (2). The thesis author generated this material in the corresponding author's laboratory. The figures and text from that thesis have now been removed from the latest online HTML and PDF versions of the article. The Editors have determined that, although some of the data in the thesis serve as a molecular and mechanistic basis for findings reported in the article, the data that remain in the article following removal of the material from the thesis are sufficient to stand independently. Numerous citations to the thesis (2) have been provided throughout the article (1) text as needed.

Footnotes

  • Mol Cancer Res 2021;19:739

  • ©2021 American Association for Cancer Research.

References

  1. 1.↵
    1. Robinson CM,
    2. Poon BPK,
    3. Kano Y,
    4. Pluthero FG,
    5. Kahr WHA,
    6. Ohh M
    . A hypoxia-inducible HIF1–GAL3ST1-sulfatide axis enhances ccRCC immune evasion via increased tumor cell–platelet binding. Mol Cancer Res 2019;17:2306–17.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Greer SN
    . Role of GAL3ST1 in renal cell carcinoma [dissertation]. Toronto (ON): University of Toronto; 2012.
PreviousNext
Back to top
Molecular Cancer Research: 19 (4)
April 2021
Volume 19, Issue 4
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Correction: A Hypoxia-Inducible HIF1–GAL3ST1–Sulfatide Axis Enhances ccRCC Immune Evasion via Increased Tumor Cell–Platelet Binding
(Your Name) has forwarded a page to you from Molecular Cancer Research
(Your Name) thought you would be interested in this article in Molecular Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Correction: A Hypoxia-Inducible HIF1–GAL3ST1–Sulfatide Axis Enhances ccRCC Immune Evasion via Increased Tumor Cell–Platelet Binding
Mol Cancer Res April 1 2021 (19) (4) 739; DOI: 10.1158/1541-7786.MCR-20-0986

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Correction: A Hypoxia-Inducible HIF1–GAL3ST1–Sulfatide Axis Enhances ccRCC Immune Evasion via Increased Tumor Cell–Platelet Binding
Mol Cancer Res April 1 2021 (19) (4) 739; DOI: 10.1158/1541-7786.MCR-20-0986
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Correction: Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non–Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2
  • Correction: Inflammatory Molecule, PSGL-1, Deficiency Activates Macrophages to Promote Colorectal Cancer Growth through NFκB Signaling
Show more Correction
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement